Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art.
about
Applications of nanotechnology in dermatologyOral insulin delivery: how far are we?Preparation and characterization of novel coenzyme Q10 nanoparticles engineered from microemulsion precursorsDrug delivery and nanoparticles:applications and hazardsNanotechnology Based Approaches for Enhancing Oral Bioavailability of Poorly Water Soluble Antihypertensive DrugsThe Role of Cell-Penetrating Peptide and Transferrin on Enhanced Delivery of Drug to BrainNanotechnology-Based Drug Delivery Systems for Photodynamic Therapy of Cancer: A ReviewInhaled nano- and microparticles for drug deliveryNanostructured lipid carriers: An emerging platform for improving oral bioavailability of lipophilic drugsSolid Lipid Nanoparticles and Nanostructured Lipid Carriers: Structure, Preparation and ApplicationNano-Therapeutics for the Lung: State-of-the-Art and Future PerspectivesSolid Lipid Nanoparticles as Efficient Drug and Gene Delivery Systems: Recent BreakthroughsNanotheranostics - application and further development of nanomedicine strategies for advanced theranosticsNanotechnology-based drug delivery systems for treatment of oral cancer: a reviewPhotoacoustic tomography: fundamentals, advances and prospectsNanostructured lipid carriers: a potential drug carrier for cancer chemotherapySmall solutions for big problems: the application of nanoparticles to brain tumor diagnosis and therapyDesign, characterization, and clinical evaluation of argan oil nanostructured lipid carriers to improve skin hydrationNanotechnology for multimodality treatment of cancer (Review)C-terminal domain deletion enhances the protective activity of cpa/cpb loaded solid lipid nanoparticles against Leishmania major in BALB/c miceDesign and optimization of PLGA-based diclofenac loaded nanoparticlesNanoparticles from renewable polymersDistribution, Sources, and Association of Polycyclic Aromatic Hydrocarbons, Black Carbon, and Total Organic Carbon in Size-Segregated Soil Samples Along a Background-Urban-Rural TransectMulti-functionality Redefined with Colloidal Carotene Carbon Nanoparticles for Synchronized Chemical Imaging, Enriched Cellular Uptake and TherapyNanoparticles as Theranostic Vehicles in Experimental and Clinical Applications-Focus on Prostate and Breast Cancer.Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come.Modulating Drug Release and Enhancing the Oral Bioavailability of Torcetrapib with Solid Lipid Dispersion Formulations.Influence of surfactant and lipid type on the physicochemical properties and biocompatibility of solid lipid nanoparticles.Polymeric micelles, a promising drug delivery system to enhance bioavailability of poorly water-soluble drugs.Preparation, characterization, pharmacokinetics and tissue distribution of solid lipid nanoparticles loaded with tetrandrine.Acoustically enhanced Evans blue dye perfusion in neurological tissues.Diazepam-loaded solid lipid nanoparticles: design and characterization.Improved brain delivery of vincristine using dextran sulfate complex solid lipid nanoparticles: optimization and in vivo evaluation.Active Targeting of Sorafenib: Preparation, Characterization, and In Vitro Testing of Drug-Loaded Magnetic Solid Lipid Nanoparticles.Unique technology for solubilization and delivery of highly lipophilic bioactive molecules.Investigation of the factors influencing the incorporation of clotrimazole in SLN and NLC prepared by hot high-pressure homogenization.Nanostructured lipid carriers as novel carrier for sunscreen formulations.Solid lipid nanoparticles and nanoemulsions containing ceramides: preparation and physicochemical characterization.Solid lipid nanoparticles bearing oxybenzone: in-vitro and in-vivo evaluation.Solid lipid budesonide microparticles for controlled release inhalation therapy.
P2860
Q24170384-B02F65C3-94A8-4D80-B591-39AA2A3DCE45Q24632900-A7D4E1DF-FDF7-4C1D-80FA-51DDF9B85649Q24648098-19617757-5F0C-4C0D-819A-49A44099A854Q24655744-BAB69762-237D-45C1-A5EB-084202495A21Q26745076-AA5C45E9-2D36-4B88-BCE6-6D97BB87CE45Q26745586-DFF4C03D-BEE3-4EDD-956F-E40334DD1D0CQ26765475-93BAB3C3-EAC6-47F1-AFDC-533D260D4D2BQ26771328-3FF7EAAA-F55C-4477-AA4C-698813AA210AQ26774831-FDC8BB06-5AC3-427F-91D9-442F8D73D6A5Q26778603-CD8D5349-36ED-48A5-A801-6C5A0183885DQ26786162-00D98B31-C4F5-480E-9898-93B7D16324B4Q26799879-3CCDA41A-2D66-4F85-ACAB-9C7103159B9DQ26860760-D4BBDD6F-A9D3-44EC-8ECC-699E14F37DD0Q26995835-AF7DA087-7777-41A8-998D-A9A6BA2D7E73Q27027215-13B0D592-6A21-4882-8962-B59F862433A9Q27027328-A04EE58D-37EA-4581-BD9C-F00F61389CC0Q28390962-09E3ACFD-8D54-49C6-A018-17174396F430Q28392702-BE597210-1696-4E19-9A9E-B9AAA1B9DAB6Q28468380-673A4468-50A1-4463-8BB3-7B72ABDC1608Q28478982-E4275877-229A-4C21-AC2C-2A096CD4F67AQ28539253-90CAA7E9-2EE1-4A30-A1FD-45789188606FQ28655569-963C101D-4A7B-4E29-9973-D29A2C2981F4Q28714289-9F550B92-FB44-4B28-8515-DE278B696E76Q28830532-9AE459A5-5F86-4BA3-8019-DF8F1201D87BQ30354652-590746D5-3189-4C3E-96B9-33542967D316Q30366990-5C8A5951-DB17-4724-8ACA-BDC20724843FQ30390764-C558D714-67DA-4EA1-92E3-439B708DC7FFQ30432397-5DC3FD42-F143-43EE-9F3F-AAA17BAE9E43Q30451024-B52CFBE3-6823-45F7-9804-C76DA607CA25Q30464963-4C4AE3EB-DB1D-4C0A-A8FA-0D58D3E10700Q30477981-96907BEE-582A-47CC-BBE6-5B0262811049Q30478733-69B6FEAF-DB80-4183-9D7B-0A1664056539Q30657827-ABF0B885-20D6-4CA6-87D6-0ACE7C75F812Q30964683-730889DD-8EF3-4520-AF10-AD03C3CA08A1Q31137587-C55714C1-923B-441E-8D7D-516EF2DA34C3Q33251072-3B0247DA-B3E6-4B22-9B4B-7B1FDD611C9AQ33335884-B592B151-5B79-4D1B-A19E-FABD82B9CF42Q33474127-030EAB89-E26B-49AF-B2A7-E10DCC6D595DQ33484906-D08B3F3A-2668-473B-9F68-03A6FD593252Q33515824-A792CA7D-101C-4771-92F8-38EE5F900D0B
P2860
Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Solid lipid nanoparticles (SLN ...... eview of the state of the art.
@ast
Solid lipid nanoparticles (SLN ...... eview of the state of the art.
@en
type
label
Solid lipid nanoparticles (SLN ...... eview of the state of the art.
@ast
Solid lipid nanoparticles (SLN ...... eview of the state of the art.
@en
prefLabel
Solid lipid nanoparticles (SLN ...... eview of the state of the art.
@ast
Solid lipid nanoparticles (SLN ...... eview of the state of the art.
@en
P1476
Solid lipid nanoparticles (SLN ...... review of the state of the art
@en
P2093
P304
P356
10.1016/S0939-6411(00)00087-4
P407
P577
2000-07-01T00:00:00Z